Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
Open Access
- 1 October 2000
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 83 (7) , 863-869
- https://doi.org/10.1054/bjoc.2000.1389
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Positron Emission Tomography Scans in the Evaluation of Postchemotherapy Residual Masses in Patients With SeminomaJournal of Clinical Oncology, 1999
- Germ Cell Tumor: Differentiation of Viable Tumor, Mature Teratoma, and Necrotic Tissue with FDG PET and Kinetic ModelingRadiology, 1999
- Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancerThe Annals of Thoracic Surgery, 1999
- A PET study of 18 FDG uptake in soft tissue massesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphomaAnnals of Oncology, 1997
- Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.Journal of Clinical Oncology, 1996
- Gallium scans in the evaluation of residual masses after chemotherapy for seminoma.Journal of Clinical Oncology, 1995
- Gallium-67-citrate imaging in extragonadal and gonadal seminomas: relationship to radiologic findings.1994
- Early detection of relapse after treatment for metastatic germ cell tumour of the testis: An exercise in medical auditClinical Oncology, 1993
- Current status of tumor markers in testicular cancer. A practical review.1992